Hydrogen Shows Promise for Treating Fatty Liver Disease in Mice
Hydrogen as a treatment candidate for non-alcoholic steatohepatitis
Research hubs: Digestive System
- Evidence type
- Review or commentary
- Authors
- Daisuke Kawai, Akinobu Takaki, Kazuhide Yamamoto
- Journal
- Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
- Year
- 2013
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 0 (OpenAlex, as of November 2026)
- Country
- Japan
TL;DR
Scientists found that hydrogen might help treat a liver disease where fat builds up in your liver (not from drinking alcohol), which is a really common problem that can seriously damage your livers if left alone.
Key Finding
Hydrogen may represent a novel therapeutic approach for non-alcoholic steatohepatitis, a progressive liver disease with limited treatment options.
Summary
This mouse study explored whether hydrogen gas might help treat non-alcoholic steatohepatitis (NASH), a liver disease where fat builds up in liver cells and causes inflammation. The research suggests hydrogen could be a new treatment option for NASH, a condition that currently has no FDA-approved medications and affects many people with metabolic disorders.
Practical Takeaway
This is early-stage research in mice, and specific results are not available. Much more research—including human studies—would be needed before hydrogen could be considered a viable NASH treatment. Anyone with liver disease should consult their doctor rather than self-treating with hydrogen water.